4.6 Review

Titanium complexes in cancer treatment

Journal

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Volume 42, Issue 3, Pages 309-315

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/S1040-8428(01)00224-4

Keywords

titanocene dichloride; bis(beta-diketonato)titanium(IV); antitumor; cancer

Ask authors/readers for more resources

A series of complexes containing titanium, Ti, as a metal center has shown to possess a wide spectrum of antitumor properties. This series belongs to the non-platinum metal antitumor agents which has been developed mainly in the past 20 years. The bis(beta-diketonato)titanium(IV) and titanocene derivatives appear to offer a different alternative for cancer chemotherapy which do not follow the rationale and mechanism of action of the platinum complexes. The hydrolysis of these complexes in aqueous and pseudo aqueous solutions is discussed and the interaction studies of titanium complexes with biomolecules are also presented to unravel the mechanism of action at molecular levels. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available